FDA Cites Swiss Vaccine Maker for Testing, Reviews

Drug Industry Daily
A A
PaxVax Berna netted itself a Form 483 after an FDA inspection revealed inadequate testing and tardy deviation reports by its Thorishaus, Switzerland facility.

To View This Article:

Login

Subscribe To Drug Industry Daily